Analysis of type 2 diabetes heterogeneity with a tree-like representation: insights from the prospective German Diabetes Study and the LURIC cohort
- PMID: 38142707
- DOI: 10.1016/S2213-8587(23)00329-7
Analysis of type 2 diabetes heterogeneity with a tree-like representation: insights from the prospective German Diabetes Study and the LURIC cohort
Abstract
Background: Heterogeneity in type 2 diabetes can be represented by a tree-like graph structure by use of reversed graph-embedded dimensionality reduction. We aimed to examine whether this approach can be used to stratify key pathophysiological components and diabetes-related complications during longitudinal follow-up of individuals with recent-onset type 2 diabetes.
Methods: For this cohort analysis, 927 participants aged 18-69 years from the German Diabetes Study (GDS) with recent-onset type 2 diabetes were mapped onto a previously developed two-dimensional tree based on nine simple clinical and laboratory variables, residualised for age and sex. Insulin sensitivity was assessed by a hyperinsulinaemic-euglycaemic clamp, insulin secretion was assessed by intravenous glucose tolerance test, hepatic lipid content was assessed by 1 H magnetic resonance spectroscopy, serum interleukin (IL)-6 and IL-18 were assessed by ELISA, and peripheral and autonomic neuropathy were assessed by functional and clinical measures. Participants were followed up for up to 16 years. We also investigated heart failure and all-cause mortality in 794 individuals with type 2 diabetes undergoing invasive coronary diagnostics from the Ludwigshafen Risk and Cardiovascular Health (LURIC) cohort.
Findings: There were gradients of clamp-measured insulin sensitivity (both dimensions: p<0·0001) and insulin secretion (pdim1<0·0001, pdim2=0·00097) across the tree. Individuals in the region with the lowest insulin sensitivity had the highest hepatic lipid content (n=205, pdim1<0·0001, pdim2=0·037), pro-inflammatory biomarkers (IL-6: n=348, pdim1<0·0001, pdim2=0·013; IL-18: n=350, pdim1<0·0001, pdim2=0·38), and elevated cardiovascular risk (nevents=143, pdim1=0·14, pdim2<0·00081), whereas individuals positioned in the branch with the lowest insulin secretion were more prone to require insulin therapy (nevents=85, pdim1=0·032, pdim2=0·12) and had the highest risk of diabetic sensorimotor polyneuropathy (nevents=184, pdim1=0·012, pdim2=0·044) and cardiac autonomic neuropathy (nevents=118, pdim1=0·0094, pdim2=0·06). In the LURIC cohort, all-cause mortality was highest in the tree branch showing insulin resistance (nevents=488, pdim1=0·12, pdim2=0·0032). Significant gradients differentiated individuals having heart failure with preserved ejection fraction from those who had heart failure with reduced ejection fraction.
Interpretation: These data define the pathophysiological underpinnings of the tree structure, which has the potential to stratify diabetes-related complications on the basis of routinely available variables and thereby expand the toolbox of precision diabetes diagnosis.
Funding: German Diabetes Center, German Federal Ministry of Health, Ministry of Culture and Science of the state of North Rhine-Westphalia, German Federal Ministry of Education and Research, German Diabetes Association, German Center for Diabetes Research, European Community, German Research Foundation, and Schmutzler Stiftung.
Copyright © 2024 Elsevier Ltd. All rights reserved.
Comment in
-
Advancing precision medicine in type 2 diabetes.Lancet Diabetes Endocrinol. 2024 Feb;12(2):87-88. doi: 10.1016/S2213-8587(23)00384-4. Epub 2023 Dec 21. Lancet Diabetes Endocrinol. 2024. PMID: 38142706 No abstract available.
Similar articles
-
Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study.Lancet Diabetes Endocrinol. 2019 Sep;7(9):684-694. doi: 10.1016/S2213-8587(19)30187-1. Epub 2019 Jul 22. Lancet Diabetes Endocrinol. 2019. PMID: 31345776
-
Estimates of insulin sensitivity from the intravenous-glucose-modified-clamp test depend on suppression of lipolysis in type 2 diabetes: a randomised controlled trial.Diabetologia. 2014 Oct;57(10):2094-102. doi: 10.1007/s00125-014-3328-3. Epub 2014 Jul 22. Diabetologia. 2014. PMID: 25047649 Clinical Trial.
-
Hyperbaric oxygen rapidly improves tissue-specific insulin sensitivity and mitochondrial capacity in humans with type 2 diabetes: a randomised placebo-controlled crossover trial.Diabetologia. 2023 Jan;66(1):57-69. doi: 10.1007/s00125-022-05797-0. Epub 2022 Sep 30. Diabetologia. 2023. PMID: 36178534 Free PMC article. Clinical Trial.
-
Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.Pharmacogenomics. 2001 Feb;2(1 Suppl 1):S1-73. doi: 10.1517/14622416.2.1.S1. Pharmacogenomics. 2001. PMID: 11258203 Review.
-
Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis.Diabetologia. 2023 Aug;66(8):1395-1412. doi: 10.1007/s00125-023-05928-1. Epub 2023 May 19. Diabetologia. 2023. PMID: 37204441 Free PMC article.
Cited by
-
Cohort profile of the Heidelberg study on diabetes and complications HEIST-DiC.Sci Rep. 2025 Aug 12;15(1):29580. doi: 10.1038/s41598-025-15343-8. Sci Rep. 2025. PMID: 40797027 Free PMC article.
-
The Twin Cycle Hypothesis of type 2 diabetes aetiology: From concept to national NHS programme.Exp Physiol. 2025 Jul;110(7):984-991. doi: 10.1113/EP092009. Epub 2025 Feb 3. Exp Physiol. 2025. PMID: 39898429 Free PMC article. Review.
-
Continuous glucose monitoring for the routine care of type 2 diabetes mellitus.Nat Rev Endocrinol. 2024 Jul;20(7):426-440. doi: 10.1038/s41574-024-00973-1. Epub 2024 Apr 8. Nat Rev Endocrinol. 2024. PMID: 38589493 Review.
-
Resident Macrophages in the Cervical Sympathetic Ganglia Participate in P2Y12 Receptor Mediated Diabetic Cardiac Autonomic Neuropathy.Mol Neurobiol. 2025 Aug;62(8):9744-9758. doi: 10.1007/s12035-025-04883-9. Epub 2025 Mar 27. Mol Neurobiol. 2025. PMID: 40146499
-
Increased cardiovascular risk in people with LADA in comparison to type 1 diabetes and type 2 diabetes: Findings from the DPV registry in Germany and Austria.Diabetes Obes Metab. 2025 Feb;27(2):563-573. doi: 10.1111/dom.16048. Epub 2024 Nov 11. Diabetes Obes Metab. 2025. PMID: 39529211 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous